Clicks Group Limited
Clicks Group Limited
Your view on CLCGY
Overview
What the company does, where it operates, and who runs it.
About Clicks Group Limited
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Bertina D. Engelbrecht B.Proc
- Headquarters
- Cnr Searle and Pontac Streets, Cape Town, ZA
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Bertina D. Engelbrecht B.Proc
- Headquarters
- Cnr Searle and Pontac Streets, Cape Town, ZA
Clicks Group Limited, together with its subsidiaries, operates as a health and beauty retailer, and pharmaceutical distributor and wholesaler in South Africa. The company operates in two segments, Retail and Distribution.
It retails pharmacy, health and beauty through approximately 840 stores, and 620 in-store pharmacies for the middle to upper income markets under the Clicks name.
The company also retails specialty health and wellness products, including vitamins, mineral and herbal supplements, sports nutrition, and slimming products under the General Nutrition Corporation (GNC) name; luxury toiletries, cosmetics, gifting, and grooming products under The Body Shop name; and fashionable jewelry and accessories for young women and girls under the Claire's name.
In addition, it is involved in the wholesale and supply of pharmaceutical products to retail pharmacies, private hospitals, dispensing doctors, and retail health stores under the UPD name. The company was formerly known as New Clicks Holdings Limited and changed its name to Clicks Group Limited in June 2009.
Clicks Group Limited was founded in 1968 and is based in Cape Town, South Africa.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Clicks Group Limited, and the rating behind it. CLCGY last traded at $39.89, 13.2× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Clicks Group Limited. Starting points for Clicks Group Limited: P/E 13.2, EPS $28.43, beta 0.25 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Clicks Group Limited. Clicks Group Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Clicks Group Limited. Trailing twelve-month EPS for Clicks Group Limited stands at $28.43. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Clicks Group Limited. Clicks Group Limited has reported as a listed company since 2010. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Clicks Group Limited valued side by side against its closest peers. Clicks Group Limited is measured against Medical - Pharmaceuticals peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Clicks Group Limited, and how their positions are changing. At a $4.71B market value, institutional positions materially move Clicks Group Limited's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Clicks Group Limited executives and directors. Shares of Clicks Group Limited have traded between $33.74 and $44.89 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Clicks Group Limited. Clicks Group Limited is a $4.71B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Clicks Group Limited. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Clicks Group Limited. Coverage tracks Clicks Group Limited within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.